Cargando…

Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease—From Brain Starch to Bench and Bedside

Alzheimer’s disease is the most common cause of dementia. Over the last three decades, research has advanced dramatically and provided a detailed understanding of the molecular events underlying the pathogenesis of Alzheimer’s disease. In parallel, assays for the detection of biomarkers that reflect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pawlowski, Matthias, Meuth, Sven G., Duning, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617942/ https://www.ncbi.nlm.nih.gov/pubmed/28703785 http://dx.doi.org/10.3390/diagnostics7030042

Ejemplares similares

Bench to Bedside: Proteomic Biomarker Analysis of Cerebrospinal Fluid in Patients With Spondylomyelopathy
por: Fiani, Brian, et al.
Publicado: (2021)

Advances in Alzheimer's Disease: From Bench to Bedside
por: Jiang, Teng, et al.
Publicado: (2015)

Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease
por: Schröder, Jens B., et al.
Publicado: (2018)

Angiotensins and Alzheimer's disease: a bench to bedside overview
por: Kehoe, Patrick G
Publicado: (2009)

Takotsubo Syndrome: From Bench to Bedside and Bedside to Bench
por: Pelliccia, Francesco, et al.
Publicado: (2022)

Recent Advances from the Bench Toward the Bedside in Alzheimer's Disease
por: Macauley, Shannon L., et al.
Publicado: (2015)

Bench-To-Bedside and Bedside Back to the Bench; Coordinating Clinical and Experimental Traumatic Brain Injury Studies
por: Agoston, Denes V., et al.
Publicado: (2012)

Bench and Bedside
por: Schmidt, Christian
Publicado: (2002)

New biomarkers in SLE: from bench to bedside
por: Capecchi, Riccardo, et al.
Publicado: (2020)

Apraxia profiles—A single cognitive marker to discriminate all variants of frontotemporal lobar degeneration and Alzheimer's disease
por: Johnen, Andreas, et al.
Publicado: (2018)

Alzheimer’s Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid
por: Huynh, Rose Ann, et al.
Publicado: (2017)

Cerebrospinal fluid biomarkers for Alzheimer's disease in Down syndrome
por: Dekker, Alain D., et al.
Publicado: (2017)

Distinguishing neurocognitive deficits in adult patients with NP-C from early onset Alzheimer’s dementia
por: Johnen, Andreas, et al.
Publicado: (2018)

Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease
por: Bader, Jakob M, et al.
Publicado: (2020)

Editorial: Nutrients and brain: from bench to the bedside
por: Cantone, Mariagiovanna, et al.
Publicado: (2023)

Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer’s disease
por: Zhou, Maotian, et al.
Publicado: (2020)

Hydrogen sulfide therapy in brain diseases: from bench to bedside
por: Zhang, Ju-yi, et al.
Publicado: (2017)

From bench to bedside
por: Verdant, Colin L
Publicado: (2012)

Clinical utility of asthma biomarkers: from bench to bedside
por: Vijverberg, Susanne JH, et al.
Publicado: (2013)

Novel Biomarkers in Sinonasal Cancers: from Bench to Bedside
por: Lechner, Matt, et al.
Publicado: (2020)

Nanomedicine and Onco-Immunotherapy: From the Bench to Bedside to Biomarkers
por: Acebes-Fernández, Vanessa, et al.
Publicado: (2020)

Staging Alzheimer’s Disease Risk by Sequencing Brain Function and Structure, Cerebrospinal Fluid, and Cognition Biomarkers
por: Chen, Guangyu, et al.
Publicado: (2016)

Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease
por: Babić, Mirjana, et al.
Publicado: (2014)

Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease
por: Janelidze, Shorena, et al.
Publicado: (2015)

Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer’s Disease Diagnosis
por: Bjerke, Maria, et al.
Publicado: (2018)

Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: Their Role in Clinical Chemistry
por: Blennow, Kaj, et al.
Publicado: (2000)

Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease in South Korea
por: Park, Sun Ah, et al.
Publicado: (2017)

Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer’s disease
por: Milà-Alomà, Marta, et al.
Publicado: (2019)

Cerebrospinal Fluid Biomarkers for the Diagnosis and Classification of Alzheimer's Disease Spectrum
por: Lee, Jongmin, et al.
Publicado: (2020)

Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease
por: Nilsson, Johanna, et al.
Publicado: (2021)

Cerebrospinal fluid microRNAs as potential biomarkers in Alzheimer’s disease
por: Noor Eddin, Ahmed, et al.
Publicado: (2023)

Research in Sickle Cell Disease: From Bedside to Bench to Bedside
por: Salinas Cisneros, Gabriel, et al.
Publicado: (2021)

Silver linings at the bench and bedside
por: Katz, Steven C., et al.
Publicado: (2020)

Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer’s disease
por: Ahmad, Shahzad, et al.
Publicado: (2020)

Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease
por: Irwin, David J., et al.
Publicado: (2020)

Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease in the Era of Disease-Modifying Treatments
por: Paraskevas, George P., et al.
Publicado: (2021)

Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
por: Jansen, Iris E., et al.
Publicado: (2022)

Oxidative homeostasis in follicular fluid and reproductive outcomes – from bench to bedside
por: Zec, Ivana, et al.
Publicado: (2022)

Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer’s disease
por: Higginbotham, Lenora, et al.
Publicado: (2020)

Bench-to-bedside review: Hypothermia in traumatic brain injury
por: Sinclair, H Louise, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_c0l77pna24au7q808jchngiu17